Ohio is One Step Closer to Unlocking Precision Medicine

More than 42 groups including leading patient advocacy organizations, medical associations, and health systems are asking members of the Ohio House Insurance Committee to support HB 608: biomarker testing legislation. This legislation would ensure more Ohioans’ can access game-changing testing which helps ensure patients get the right treatment at the right time by allowing doctors to precisely target a patient’s individual cancer.

More information on the biomarker testing legislation and the current list of industry support can be found here.